Consolidated Statements of Cash Flows - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2021
Operating Activities
Net loss attributable to common stockholders	$ (13,318,408)	$ (41,864,705)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense	3,971,342	2,814,775
Change in fair value of derivative liability	5,863,127	19,655,296
Depreciation expense		14,668
Discount on convertible notes payable	396,893	51,000
Fair value of share purchase warrants issued	179,077	83,724
Gain on settlement of debt	(1,319,326)	(18,683,279)
Gain on forgiveness of debt		(255,992)
Impairment of joint venture		35,250
Shares issued for commitment fee		1,139,250
Shares issued for services	1,072,378	29,353,966
Changes in operating assets and liabilities:
Prepaid expenses	(182,935)	(783,102)
Accounts payable and accrued liabilities	152,653	1,102,014
Due to related parties	166,680	(419,303)
Net Cash Used In Operating Activities	(3,018,519)	(7,756,438)
Investing Activities
Acquisition of property and equipment	(3,896)	(5,440,087)
Purchase of water rights/intangible assets		(1,643,160)
Net Cash Used In Investing Activities	(3,896)	(7,083,247)
Financing Activities
Proceeds from issuance of convertible notes payable	2,522,250	1,395,000
Proceeds from bank loan	255,992
Proceeds from exercise of share purchase warrants		862,500
Proceeds from issuance of common shares, net of issuance costs	2,600,000	25,931,451
Repayment of convertible note payable	(1,533,274)	(1,295,202)
Repayment of loans payable		(59,236)
Share subscriptions received		18,750
Net Cash Provided By Financing Activities	3,844,968	26,853,263
Change in Cash	822,553	12,013,578
Cash - Beginning of Period	7,371	829,924
Cash - End of Period	$ 829,924	$ 12,843,502